Use of progestin-only drospirenone-based pills in hyperandrogenic women with polycystic ovary syndrome.

Arch Gynecol Obstet · 2025 · PMC12589320 · PMID 40928522

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Conclusions In this study, we demonstrated a reduction of clinical scores of hyperandrogenism (acne et hirsutism) in PCOS patients who underwent a DRSP-only 6-month therapy, as well as a significant reduction in 17-OH-progesterone levels after therapy and a decreasing trend for CRP values.

also in 47,180 other papers

showed a trendno p-value reported

It also lowered 17-OH-progesterone levels and showed a trend of reduced CRP values.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.